Phenyloxadiazole derivatives as PGDS inhibitors

摘要

This invention is directed to a compound of formula (I):;
wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).

主权项

1. A compound of formula (I): wherein R1 is hydrogen or C1-C6 alkyl; R2 is hydrogen, halogen or C1-C3 alkyl; and R3 is hydroxyalkyl.